About This Event

Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Mathai Mammen, M.D., Ph.D., Chairman, CEO and President of Parabilis Medicines, rings the Closing Bell.